1
|
Tate PS, Marquioni-Ramella MD, Cerchiaro C, Suburo AM. Ilex paraguariensis Extracts Prevent Oxidative Damage in a Mouse Model of Age-Related Macular Degeneration. Mol Nutr Food Res 2022; 66:e2100807. [PMID: 35279946 DOI: 10.1002/mnfr.202100807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2021] [Revised: 02/23/2022] [Indexed: 11/11/2022]
Abstract
Age-related macular degeneration (AMD), a chronic disease of the retina, leads to severe visual loss. AMD affects the retinal pigment epithelium (RPE) and the visual cells (photoreceptors). RPE failure, the first step of this disease, is associated with oxidative stress. Since antioxidants can slow down AMD progression, the intake of foods and drinks rich in antioxidant compounds may reduce retinal damage. Ilex paraguariensis (yerba mate, YM) extracts reduce oxidative damage of RPE cells in vitro as shown in previous study. Here, the effects of YM drinking on RPE and photoreceptor survival after oxidative damage with sodium iodate (NaIO3; SI) in a murine AMD model are described. Funduscopy and histology show that YM treatment prevents RPE and photoreceptor damage. YM also increases the expression of NRF2, the master antioxidant gene, and its effectors HO-1 and SOD2. In mice receiving YM and SI, the antioxidant response is larger than in mice receiving YM or SI alone. The YM drink also increases expression of RPE65, a gene that is involved in the functionality and survival of photoreceptors and RPE cells. The results suggest YM can play an important role in the prevention of retinal damage associated with oxidative stress, such as AMD.
Collapse
Affiliation(s)
- Pablo S Tate
- Instituto de Investigaciones en Medicina Traslacional (IIMT, Universidad Austral-CONICET), Facultad de Ciencias Biomédicas, Universidad Austral, Pilar, Buenos Aires, B1629AHJ, Argentina
| | - Melisa D Marquioni-Ramella
- Instituto de Investigaciones en Medicina Traslacional (IIMT, Universidad Austral-CONICET), Facultad de Ciencias Biomédicas, Universidad Austral, Pilar, Buenos Aires, B1629AHJ, Argentina
| | - Constanza Cerchiaro
- Instituto de Investigaciones en Medicina Traslacional (IIMT, Universidad Austral-CONICET), Facultad de Ciencias Biomédicas, Universidad Austral, Pilar, Buenos Aires, B1629AHJ, Argentina
| | - Angela M Suburo
- Instituto de Investigaciones en Medicina Traslacional (IIMT, Universidad Austral-CONICET), Facultad de Ciencias Biomédicas, Universidad Austral, Pilar, Buenos Aires, B1629AHJ, Argentina
| |
Collapse
|
2
|
Racic T, Chang A, Fernando N, Brandli A, Natoli R, Penfold P, Provis JM, Rutar M. Anti-inflammatory and neuroprotective properties of the corticosteroid fludrocortisone in retinal degeneration. Exp Eye Res 2021; 212:108765. [PMID: 34509498 DOI: 10.1016/j.exer.2021.108765] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2021] [Revised: 08/05/2021] [Accepted: 09/08/2021] [Indexed: 12/20/2022]
Abstract
The pathogenesis of outer retinal degenerations has been linked to the elevation of cytokines that orchestrate pro-inflammatory responses within the retinal milieu, and which are thought to play a role in diseases such as geographic atrophy (GA), an advanced form of AMD. Here we sought investigate the anti-inflammatory and mechanistic properties of fludrocortisone (FA), as well as triamcinolone acetonide (TA), on Müller cell-mediated cytokine expression in response to inflammatory challenge. In addition, we investigated the neuroprotective efficacy of FA and TA in a photo-oxidative damage (PD), a model of outer retinal degeneration. Expression of CCL2, IL-6, and IL-8 with respect to FA and TA were assessed in Müller cells in vitro, following simulation with IL-1β or TNF-α. The dependency of this effect on mineralocorticoid and glucocorticoid signaling was also interrogated for both TA and TA via co-incubation with steroid receptor antagonists. For the PD model, C57BL/6 mice were intravitreally injected with FA or TA, and changes in retinal pathology were assessed via electroretinogram (ERG) and optical coherence tomography (OCT). FA and TA were found to dramatically reduce the expression of CCL2, IL-6, and IL-8 in Müller glia in vitro after inflammatory challenge with IL-1β or TNF-α (P < 0.05). Though FA acts as both a mineralocorticoid and glucocorticoid receptor agonist, co-incubation with selective steroid antagonists revealed that the suppressive effect of FA on CCL2, IL-6, and IL-8 expression is mediated by glucocorticoid signaling (P < 0.05). In PD, intravitreal FA was found to ameliorate outer-retinal atrophy as measured by ERG and OCT (P < 0.05), while TA had no significant effect (P > 0.05). Our data indicate potent anti-inflammatory and mechanistic properties of corticosteroids, specifically FA, in suppressing inflammation and neurodegeneration degeneration associated with outer retinal atrophy. Taken together, our findings indicate that corticosteroids such as FA may have value as a potential therapeutic for outer retinal degenerations where such pro-inflammatory factors are implicated, including AMD.
Collapse
Affiliation(s)
- Tanja Racic
- John Curtin School of Medical Research, The Australian National University, ACT, Australia
| | - Andrew Chang
- Sydney Retina Clinic & Day Surgery, Sydney, NSW, Australia; Save Sight Institute, The University of Sydney, NSW, Australia
| | - Nilisha Fernando
- John Curtin School of Medical Research, The Australian National University, ACT, Australia
| | - Alice Brandli
- Department of Anatomy and Physiology, The University of Melbourne, VIC, Australia
| | - Riccardo Natoli
- John Curtin School of Medical Research, The Australian National University, ACT, Australia; ANU Medical School, The Australian National University, ACT, Australia
| | - Philip Penfold
- John Curtin School of Medical Research, The Australian National University, ACT, Australia
| | - Jan M Provis
- John Curtin School of Medical Research, The Australian National University, ACT, Australia; ANU Medical School, The Australian National University, ACT, Australia
| | - Matt Rutar
- Department of Anatomy and Physiology, The University of Melbourne, VIC, Australia; Centre for Research in Therapeutic Solutions, Faculty of Science and Technology, University of Canberra, ACT, Australia.
| |
Collapse
|
3
|
Lee SJ, Wang W, Jin L, Lu X, Gao L, Chen Y, Liu T, Emery D, Vukmanic E, Liu Y, Kaplan HJ, Dean DC. Rod photoreceptor clearance due to misfolded rhodopsin is linked to a DAMP-immune checkpoint switch. J Biol Chem 2021; 296:100102. [PMID: 33214223 PMCID: PMC7949052 DOI: 10.1074/jbc.ra120.016053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2020] [Revised: 11/13/2020] [Accepted: 11/19/2020] [Indexed: 01/19/2023] Open
Abstract
Chronic endoplasmic reticulum stress resulting from misfolding of the visual pigment rhodopsin (RHO) can lead to loss of rod photoreceptors, which initiates retinitis pigmentosa, characterized initially by diminished nighttime and peripheral vision. Cone photoreceptors depend on rods for glucose transport, which the neurons use for assembly of visual pigment-rich structures; as such, loss of rods also leads to a secondary loss of cone function, diminishing high-resolution color vision utilized for tasks including reading, driving, and facial recognition. If dysfunctional rods could be maintained to continue to serve this secondary cone preservation function, it might benefit patients with retinitis pigmentosa, but the mechanisms by which rods are removed are not fully established. Using pigs expressing mutant RHO, we find that induction of a danger-associated molecular pattern (DAMP) "eat me" signal on the surface of mutant rods is correlated with targeting the live cells for (PrCR) by retinal myeloid cells. Glucocorticoid therapy leads to replacement of this DAMP with a "don't eat me" immune checkpoint on the rod surface and inhibition of PrCR. Surviving rods then continue to promote glucose transport to cones, maintaining their viability.
Collapse
Affiliation(s)
- Sang Joon Lee
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Ophthalmology, Kosin University College of Medicine, Seo-gu, Busan, Korea
| | - Wei Wang
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA
| | - Lei Jin
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Ophthalmology, The Third People's Hospital of Dalian, Dalian Medical University, Dalian, China
| | - Xiaoqin Lu
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Medicine, University of Louisville Health Sciences Center, Louisville, Kentucky, USA
| | - Lei Gao
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Hematology, Xinqiao Hospital, Third Military Medical University, Chongqing, China
| | - Yao Chen
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha, China
| | - Tingting Liu
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Ophthalmology, The Third People's Hospital of Dalian, Dalian Medical University, Dalian, China
| | - Douglas Emery
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Medicine, University of Louisville Health Sciences Center, Louisville, Kentucky, USA
| | - Eric Vukmanic
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Medicine, University of Louisville Health Sciences Center, Louisville, Kentucky, USA
| | - Yongqing Liu
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Medicine, University of Louisville Health Sciences Center, Louisville, Kentucky, USA
| | - Henry J Kaplan
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA
| | - Douglas C Dean
- Department of Ophthalmology and Visual Sciences, University of Louisville Health Sciences Center, Louisville, Kentucky, USA; Department of Medicine, University of Louisville Health Sciences Center, Louisville, Kentucky, USA.
| |
Collapse
|